Quick Answer
Zomedica Corp. reported Stockholders Equity of $115.40 million for the year ending 2025.
- Zomedica Corp. showed a decrease of -41.0% in Stockholders Equity from 2024 to 2025.
- This data is from Zomedica Corp.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $2.47 million | Q2 2017: $3.88 million | Q3 2017: $5.83 million | Q1 2018: $3.63 million | Q2 2018: $4.73 million | Q3 2018: $2.91 million | Q1 2019: -$1.88 million | Q2 2019: $7.68 million | Q3 2019: $5.03 million | Q1 2020: $1.95 million | Q2 2020: $29.58 million | Q3 2020: $87.96 million | Q1 2021: $277.53 million | Q2 2021: $276.07 million | Q3 2021: $271.56 million | Q1 2022: $269.04 million | Q2 2022: $266.22 million | Q3 2022: $268.78 million | Q1 2023: $263.06 million | Q2 2023: $259.48 million | Q3 2023: $260.88 million | Q1 2024: $231.90 million | Q2 2024: $208.72 million | Q3 2024: $202.84 million | Q1 2025: $132.44 million | Q2 2025: $125.36 million | Q3 2025: $119.69 million.
- Over the full 11 years of available data (2015 to 2025), Zomedica Corp.'s Stockholders Equity has grown by 3,280.1%.
- Historical annual values: Fiscal year 2025: $115.40 million | Fiscal year 2024: $195.66 million | Fiscal year 2023: $240.02 million | Fiscal year 2022: $267.39 million | Fiscal year 2021: $270.89 million | Fiscal year 2020: $51.07 million | Fiscal year 2019: $2.10 million | Fiscal year 2018: $3.66 million | Fiscal year 2017: $4.39 million | Fiscal year 2016: $3.83 million | Fiscal year 2015: $3.41 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: